Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
This video discusses current research on thimerosal-containing vaccines and the prevalence of autism and autistic-spectrum disorders. References and Resources Chez MG, Chin K, Hung PC. Immunizations, immunology, and…
Paula Busse, MD, Assistant Professor, Medicine and Clinical Immunology, Mount Sinai School of Medicine, discusses hereditary angioedema. References and Resources Vacca VM Jr. Hereditary angioedema: a case study.…
This video discusses how significant excess bleeding halted a trial of idraparinux for stroke prevention in patients with atrial fibrillation. References and Resources The Amadeus Investigators. Comparison of…
According to results from this case-control study, statin use is associated with a reduced risk of Parkinson’s disease. From our partners at VerusMed verusmed.com Sponsored by VerusMed
The following is a PSA about the Meningitis vaccine from the National Foundation for Infectious Diseases Sponsored by the National Foundation for Infectious Diseases
The FDA announced a nationwide recall of all lots of heparin and saline pre-filled flush syringes due to contamination with Serratia marcescens, a bacterium that can cause serious…
Paula Busse, MD, Assistant Professor, Medicine and Clinical Immunology, Mount Sinai School of Medicine, discusses the role of Chinese herbal treatments for asthma. References and Resources Busse PJ,…
Paula Busse, MD, Assistant Professor, Medicine and Clinical Immunology, Mount Sinai School of Medicine, discusses the role of TNFα treatments in asthma. References and Resources Busse PJ, Zhang…
The U.S. FDA issued an Early Communication regarding the agency’s ongoing review of Vytorin based on preliminary results from a recently completed study. References and Resources FDA Issues…
